Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen

Authors

Iheoma Y. Nwaogu, Washington University School of Medicine in St. Louis
Oluwadamilola M. Fayanju, Washington University School of Medicine in St. Louis
Donna B. Jeffe, Washington University School of Medicine in St. LouisFollow
Julie A. Margenthaler, Washington University School of Medicine in St. Louis

Journal

Molecular and Clinical Oncology

Publication Date

2015

Volume

3

Inclusive Pages

1117-1122

Document Type

Open Access Publication

DOI

10.3892/mco.2015.579

Rights and Permissions

Nwaogu, I.Y., Fayanju, O.M., Jeffe, D.B., & Margenthaler, J.A. (2015). Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen. Molecular and Clinical Oncology, 3, 1117-1122. http://dx.doi.org/10.3892/mco.2015.579

Recommended Citation

Nwaogu, Iheoma Y.; Fayanju, Oluwadamilola M.; Jeffe, Donna B.; and Margenthaler, Julie A., "Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen." Molecular and Clinical Oncology. 3, 1117-1122. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4401